Integrative Proteomic and Transcriptomic Profiling Identifies Candidate Biomarkers for Discriminating Anaphylactic from Cardiac Sudden Death
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27052166 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Zhi-Hao Fan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Medicine, School of Basic Medical Sciences, Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: Death, Sudden, Cardiac, Biomarkers, Proteomics, Anaphylaxis. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Heilongjiang Province;Harbin Medical University Postgraduate Research and Practical Innovation Project, Natural Science Foundation of Heilongjiang Province, Harbin Medical University Postgraduate Research and Practical Innovation Project.
Abstract (Originalsprache)
To address the forensic diagnostic challenge of distinguishing Anaphylactic Sudden Death (ASD) from Sudden Death from Coronary Heart Disease (SD-CHD), this study established Ldlr−/− mouse models of Atherosclerosis (AS) and ovalbumin-induced Anaphylaxis (AP). LC-MS/MS-based serum proteomic analysis of Atherosclerosis (AS) and Anaphylaxis (AP) mice identified fibronectin 1 (FN1), platelet glycoprotein Ibα chain (GP1BA), and platelet factor 4 (PF4) as candidate biomarkers. These candidates were validated by parallel reaction monitoring (PRM), enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry (IHC) in a combined AS + AP mouse model and in post-mortem human cardiac and bronchiolar epithelial tissue. In mice, serum FN1, GP1BA, and PF4 levels were significantly elevated in the AS group, whereas only FN1 was markedly downregulated in AP mice. In human tissues, FN1, GP1BA, and PF4 were all upregulated in Sudden death from coronary heart disease (SD-CHD) myocardial samples, with FN1 showing the greatest increase. In airway epithelium, FN1 was upregulated in anaphylactic sudden death (ASD) and anaphylactic sudden death (ASD) with Coronary Atherosclerosis (ASD + CAS) groups, while GP1BA was downregulated. These results indicate that FN1 serves as a key differential mouse serum biomarker, while PF4 and GP1BA aid in Sudden death from coronary heart disease (SD-CHD) diagnosis. Collectively, this multimarker, multilevel framework provides a molecular diagnostic strategy for the forensic identification of complex sudden death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Forensic Medicine, School of Basic Medical Sciences, Harbin Medical University, Harbin 150081, China.
- Department of Pathophysiology, School of Basic Medical Sciences, Harbin Medical University, Harbin 150081, China.
ORCID-Profile: He Chen
Förderung
- Natural Science Foundation of Heilongjiang Province;Harbin Medical University Postgraduate Research and Practical Innovation Project
- Natural Science Foundation of Heilongjiang Province
- Harbin Medical University Postgraduate Research and Practical Innovation Project
Zitieren
APA
Fan, Z. H., Yue, Z. Q., Liu, Z. K., Jin, Z. F., Zhang, W. H., & Chen, H. (2026). Integrative Proteomic and Transcriptomic Profiling Identifies Candidate Biomarkers for Discriminating Anaphylactic from Cardiac Sudden Death. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052166
Vancouver
Fan ZH, Yue ZQ, Liu ZK, Jin ZF, Zhang WH, Chen H. Integrative Proteomic and Transcriptomic Profiling Identifies Candidate Biomarkers for Discriminating Anaphylactic from Cardiac Sudden Death. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052166
BibTeX
@article{Fan2026,
author = {Fan, Zhi-Hao and Yue, Zi-Qi and Liu, Zi-Kang and Jin, Zhan-Feng and Zhang, Wei-Hua and Chen, He},
title = {Integrative Proteomic and Transcriptomic Profiling Identifies Candidate Biomarkers for Discriminating Anaphylactic from Cardiac Sudden Death},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27052166}
}
EUVIMED